United States · FDA National Drug Code directory
Imatinib Mesylate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 82009-087_8d48cd1c-474c-49f9-8e70-aa7525bb1087
- Product NDC
- 82009-087
- Form
- TABLET, FILM COATED
- Composition / generic term
- Imatinib Mesylate
- Labeler
- QUALLENT PHARMACEUTICALS HEALTH LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230901
- Source listing expiry
- 20271231
Source-listed ingredients
- IMATINIB MESYLATE — 400 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (82009-087-30) · 82009-087-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →